Skip to main content
  1. aggrego News
  2. Colorectal Cancer

Addition of Atezolizumab to FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer

Recommended
A Genetic Variant in CD274 Is Associated With Prognosis in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Based Chemotherapy
ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
Association Between Germline Variants and Somatic Mutations in Colorectal Cancer
Addition of Atezolizumab to FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer
Largest Study to Date Supports CRC Screening Before Age 50 
RNF43 G659fs is an Oncogenic Colorectal Cancer Mutation and Sensitizes Tumor Cells to PI3K/mTOR Inhibition
Muscarinic Receptor Activation in Colon Cancer Selectively Augments Pro-Proliferative microRNA-21, microRNA-221 and microRNA-222 Expression
Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer

Addition of Atezolizumab to FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer

header-info
Jun. 20, 2022
social-elements

The addition of atezolizumab to FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, irinotecan) and bevacizumab improved progression-free survival in the first-line treatment of patients with metastatic colorectal cancer.

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2022 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • AML+CLL
  • Breast Cancer
  • CAR-T Cell Therapy
  • Chronic ITP
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • Early Breast Cancer
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Graft Versus Host Disease
  • Gynecologic Cancer
  • Head And Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • HER2 Low mBC
  • Immuno Oncology

Additional navigation- 2

  • Liver Cancer
  • Lung Cancer
  • Marginal Zone Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Non-Small-Cell Lung Cancer
  • Oncology Nursing
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pediatric Oncology
  • Prostate Cancer
  • Radiation Oncology
  • Renal Cell Carcinoma
  • RET+ Advanced Thyroid Cancer
  • RET+ NSCLC
  • Sarcoma
  • Skin Cancer
  • Solid Tumors
  • Supportive Care
  • Surgical Cancer
  • Urethral Carcinoma